Kala Pharmaceuticals stock rockets ze li 300% tom qab FDA OKs IND daim ntawv thov rau PCED kev kho mob

Shares ntawm Kala Pharmaceuticals Inc.
KALA,
+ 219.90%
quadrupled nyob rau hauv volatile heev trading hnub Wednesday, tom qab lub biopharmaceutical tuam txhab uas muag hais tias lub Food and Drug Administration tau txais nws cov tshuaj tshiab tshuaj ntsuam xyuas (IND) daim ntawv thov rau KPI-012, nws kev kho mob ntawm corneal epithelial defect (PCED). Nrog rau qhov kev lees paub, lub tuam txhab tau hais rau hnub Tuesday lig tias nws tab tom nrhiav los pib qhov kev sim theem 2 KPI-012 hauv thawj peb lub hlis twg ntawm 2023. Cov khoom lag luam tau nce 274.2% hauv nruab nrab kev lag luam. Volume spiked mus rau 30.3 lab shares, piv nrog rau tag nrho-hnub nruab nrab ntawm txog 118,100 shares. Cov Tshuag tau raug tso tseg rau lub sij hawm rau volatility txij li thaum qhib lub tswb. Cais, lub tuam txhab tau hais tias nws tau nce $ 25 lab los ntawm kev muag tag nrho ntawm 43,478 shares ntawm Series E convertible nyiam Tshuag ntawm $ 575.00 ib feem rau "tus neeg ua lag luam tsom mus rau lub neej." Txawm tias muaj kev sib tw, Kala cov Tshuag tau poob 75.8% hauv 2022, thaum iShares Biotechnology ETF
IB,
-0.59%
tau plam 16.0% thiab S&P 500
SPX,
-0.72%
tau poob 20.4%.